United States, Feb. 6 -- Seqirus USA Inc., Summit, New Jersey, has been awarded a maximum $15,969,518 firm-fixed-price, indefinite-quantity contract for injectable egg-free influenza vaccines. This was a competitive acquisition with two responses received. This is a one-year contract with no option periods. Location of performance is North Carolina, with a Feb. 5, 2027, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps, and Coast Guard. Type of appropriation is fiscal 2026 through 2027 defense working capital funds. The contracting activity is Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-26-D-0006).
Published by HT Digital Content Services with permission from Pivotal Sources....